Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Molecular basis of disease > Diabetes and Hypoglycaemia > Flashcards

Diabetes and Hypoglycaemia Flashcards

1
Q

How are blood glucose levels maintained?

A
  • Dietary carbohydrate
  • Glycogenolysis
  • Gluconeogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Role of the liver in glucose metabolism

A

After meals- stores glucose as glycogen

During fasting- makes glucose available through glycogenolysis and gluconeogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe glucose homeostasis in a fed state

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe glucose homeostasis in a fasting state

A

Decrease in:

  • insulin
  • peripheral uptake

Increase in (glucose production):

  • lipolysis, proteolysis
  • liver gluconeogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is regulation of glucose essential?

A

· Brain and erythrocytes require continuous supply, therefore we need to avoid deficiency of glucose

· High glucose and metabolites cause pathological changes to tissues e.g. micro/macro vascular diseases, neuropathy: - therefore we need to avoid excess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Insulin

A

hormone which regulates blood glucose levels by storing glucose into tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Actions of insulin in the liver

A
  • Stores glucose in the form of glycogen after eating (increases glycogen synthesis)
  • Decreases gluconeogenesis (because we don’t want to increase blood glucose after eating)
  • Increases lipogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Actions of insulin in striated muscle

A
  • Increases glucose uptake from plasma/blood
  • Increases glycogen synthesis
  • Increases protein synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Actions of insulin in adipose tissue

A
  • Increases glucose uptake
  • Increases lipogenesis
  • Decreases lipolysis (because when lipids are broken down they can be used to produce glucose via gluconeogenesis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the counter-regulatory hormones of insulin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is diabetes mellitus?

A

a metabolic disorder characterised by:

  • chronic hyperglycaemia
  • glycosuria (glucose in your urine)
  • abnormalities of lipid and protein metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is there hyperglycaemia and glycosuria in diabetes mellitus?

A

The hyperglycaemia results from increased hepatic glucose production and decreased cellular glucose uptake

Blood glucose > ~10mmol/L exceeds renal threshold → glycosuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Classification of diabetes

A

Type I Diabetes - INSULIN DEFICIENT
Type II Diabetes - INSULIN RESISTANT
Secondary Diabetes
Gestational Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Secondary Diabetes

A

brought on by other diseases, medical conditions, and medications

Chronic pancreatitis, pancreatic surgery, secretion of antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gestational Diabetes

A

a form of diabetes mellitus that occurs during some pregnancies

blood glucose levels will usually go back to normal after birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Type I Diabetes

A

Insulin secretion is deficient due to autoimmune destruction of β-cells in pancreas by T-cells

· Predominantly in children and young adults; but other ages as well
· Sudden onset (days/weeks)
· Appearance of symptoms may be preceded by ‘pre-diabetic’ period of several months

strong link with HLA genes within the MHC region on chromosome 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pathogenesis of Type I Diabetes

A

HLA Class II on β-cell surface presents as foreign and self-antigens (autoantigens) to T-lymphocytes to initiate autoimmune response

Circulating autoantibodies against these antigens:
· Glutamic acid decarboxylase
· Tyrosine-phosphate-like molecule
· Islet auto-antigen

Destruction of β-cells with decreased insulin secretion (deficient) → Type I Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does destruction of pancreatic β-cells in Type I diabetes lead to?

A

HYPERGLYCAEMIA

-due to absolute deficiency of insulin and amylin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is amylin?

A

glucoregulatory peptide hormone co-secreted with insulin which lowers blood glucose by slowing gastric emptying & suppressing glucagon output from pancreatic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Metabolic complications of Type I Diabetes

A

During hyperglycaemia:
- Brain responds to hyperglycaemia with polyphagia (excessive eating) in an attempt to increase insulin levels and store glucose (however insulin is not being produced!)

  • Kidneys are not able to reabsorb all of the blood glucose, and so glucose will pass into the urine→glycosuria.
  • Increased levels of glucose in kidneys causes an osmotic effect, and so more water will be secreted into urine, causing polyuria (increased urination).
  • As you urinate more, you can become dehydrated→volume depletion. Volume depletion will increase your thirst, causing polydipsia (excessive thirst) so you can replenish that volume. If the volume is not replenished, it can lead to a diabetic coma.

Furthermore, insulin deficiency causes:

  • Increased lipolysis
  • Causing increased fatty acids (FFA)
  • Increased FFA undergo β-oxidation in the liver, producing ketone bodies
  • Increased ketone bodies lead to ketoacidosis (DKA), which can also lead to a diabetic coma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Type II Diabetes

A

Insulin secretion is retained but there is target organ resistance to the actions of insulin

· Slow onset (months/years)
· Patients middle aged/elderly- prevalence increases with age
· Strong familiar incidence
· Pathogenesis uncertain- insulin resistance, β-cell dysfunction:
>may be due to lifestyle factors- obesity, lack of exercise

22
Q

Describe the pathophysiology of type II DM

A
23
Q

Metabolic complications of type II diabetes

A

Type 2 diabetes mellitus causes Hyper-osmolar non-ketotic coma (HONK)

[Hyperosmolar Hyperglycaemia State (HSS)]

  • Development of severe hyperglycaemia
  • Extreme dehydration
  • Increased plasma osmolality
  • Impaired consciousness
  • No ketosis
  • Death if untreated
24
Q

Approaches to diagnosing diabetes

A

We test for diabetes depending on whether there are symptoms present or not

25
Q

Diagnosis of diabetes in the presence of symptoms

A

In the presence of symptoms: polyuria, polydipsia & weight loss for Type I diabetes

Random plasma glucose ≥11.1mmol/L (200mg/dL)

OR

Fasting plasma glucose ≥7.0mmol/L (126mg/dL). Fasting is defined as no caloric intake for at least 8 hours

OR

Oral glucose tolerance test (OGTT)- plasma glucose ≥11.1mmol/L

26
Q

Diagnosis of diabetes in the absence of symptoms

A

Test blood samples on 2 separate days

27
Q

Impaired glucose tolerance (IGT)

A

A disorder in which blood glucose levels become elevated which may signal borderline diabetes mellitus (pre-diabetes)

Fasting plasma glucose <7mmol/L
AND
OGTT value of 7.8-11.1mmol

28
Q

Impaired fasting glycaemia (IFG)

A

A disorder in which blood glucose levels become elevated during period of fasting, but not enough to prompt a diagnosis of diabetes mellitus (pre-diabetes)

Fasting plasma glucose 6.1 to 6.9mmol/L
AND
OGTT value of <7.8mmol/L

29
Q

Why is an oral glucose tolerance test (OGTT) performed?

A

performed to confirm a diagnosis of:

  • diabetes mellitus
  • acromegaly (too much GH)
30
Q

How is an OGTT performed?

A

· 75g oral glucose administered
· blood samples collected at 0 and 120 mins after glucose
· subjects tested fasting after 3 days or normal diet containing at least 250g carbohydrate

If the blood glucose levels become ≥11.1 mmol/L, then you may have diabetes.

31
Q

Treatment of Type I diabetes

A

insulin therapy

32
Q

Treatment of Type II diabetes

A

Healthier diet and regular exercise are recommended as treatment at first.

Oral Medications:

  • metoformin
  • sulphonylureas
  • Thiazolidinediones
  • SGLT2 inhibitors
  • dipeptidyl peptidase inhibitor (DDP-4; Gliptins)
33
Q

Metformin (type II diabetes)

A
  • decreases gluconeogenesis and increases peripheral utilisation of glucose
  • acts only in the presence of endogenous insulin meaning it is effective only if there are some residual functioning pancreatic islet cells
  • the drug helps type 2 diabetics respond better to their own insulin, lower the amount of sugar created by the liver, and decreasing the amount of sugar absorbed by the intestines
34
Q

Sulphonylureas (type II diabetes)

A

work mainly by stimulating the cells in the pancreas to make more insulin

also help insulin to work more effectively in the body

35
Q

Dipeptidyl Peptidase Inhibitor (DPP-4; Gliptins) -type II diabetes

A

block the action of DPP-4, an enzyme which destroys the hormone incretin

incretin helps the body produce more insulin only when it is needed and reduces the amount of glucose being produced by the liver when it is not needed

36
Q

Why is glycaemic control important?

A

To prevent complications or avoid hypoglycaemia

37
Q

Monitoring Glycaemic Control

A

Self-monitoring to be encouraged:
· capillary blood measurement
· urine analysis: glucose in urine gives indication of blood glucose concentration above renal threshold

3-4 months: blood HbA1c (glycated Hb; covalent linkage of glucose to residue in Hb).

Others: urinary albumin (index of risk of progression to nephropathy)

38
Q

Long term complications of diabetes (both type I and II)

A

· Microvascular disease: retinopathy, nephropathy, neuropathy

· Macrovascular disease: related to atherosclerosis heart attack/stroke

39
Q

Hypoglycaemia

A

low blood glucose concentration

Defined as plasma glucose <2.5mmol/L

40
Q

What is the most common cause of hypoglycaemia?

A

Drugs

  • common in type I
  • insulin & insulin secretagogues in type II patients (less common)
  • uncommon in patients who do not have drug treated diabetes mellitus. In these patients hypoglycaemia may be caused by alcohol, critical illnesses such as hepatic, renal or cardiac failure, sepsis, hormone deficiency, inherited metabolic dx.
41
Q

Hypoglycaemia in diabetes is caused by

A

Sulfonylureas: exogenous insulin & insulin secretagogues such as:

  • glyburide
  • glipizide
  • glimepiride

these stimulate endogenous insulin, suppressing hepatic and renal glucose production and increase glucose utilisation

42
Q

Hypoglycaemia in patients without diabetes is caused by:

A

· Drugs such as alcohol (ethanol)
-ethanol inhibits gluconeogenesis, but not glycogenolysis, resulting in hepatic depletion of glycogen

· Other drugs most commonly found to cause hypoglycaemia are quinolone, quinine, beta blockers, ACE inhibitors and IGF-1.

· Endocrines disease; e.g. cortisol disorder

· Inherited metabolic disorders e.g. hereditary fructose intolerance

· Insulinoma (tumour of the pancreas which produces more insulin)

· Others: severe liver disease, non-pancreatic tumours (beta cell hyperplasia), renal disease (metabolic acidosis, reduced insulin elimination)

Sepsis
-cytokines are produced in sepsis which accelerate glucose utilisation and induce inhibition of gluconeogenesis during glycogen depletion

CKD
-mechanism not clear, but likely to involve impaired gluconeogenesis, reduced renal clearance of insulin and reduced renal glucose production

43
Q

What is reactive hypoglycaemia?

A

Post-prandial hypoglycaemia
-drop in blood glucose levels within four hours after eating

Can occur in people with and without diabetes

44
Q

What is reactive hypoglycaemia?

A

Post-prandial hypoglycaemia
-drop in blood glucose levels within four hours after eating

Can occur in people with and without diabetes

45
Q

Cause of reactive hypoglycaemia

A

Cause is unclear:

  • Possibly a benign (non-cancerous) tumour in the pancreas causing an overproduction of insulin
  • Too much glucose may be used up by the tumour itself
  • Deficiencies in counter-regulatory hormones e.g. glucagon
46
Q

Response to hypoglycaemia in normal patients

A

1st line of defence: Pancreatic β-cell secretion of insulin decreases

> hepatic glycogenolysis and gluconeogenesis is increased

> reduced glucose utilisation of peripheral tissue, including lipolysis and proteolysis

2nd line of defence: Counter Regulatory Hormones Release e.g. glucagon, epinephrine, cortisol and GH

> glucagon stimulates hepatic glycogenolysis

> epinephrine from adrenal gland stimulates hepatic glycogenolysis and gluconeogenesis (renal gluconeogenesis too)

> if hypoglycaemia is prolonged beyond 4 hours, cortisol and GH will support glucose production and limit utilisation

47
Q

What signals for the 2nd line of defence (release of counter regulatory hormones) in response to hypoglycaemia?

A

autonomic nervous system sends signals to the adrenal gland and pancreas to release counter-regulatory hormones in the defence against hypoglycaemia.

48
Q

Signs and symptoms of hypoglycaemia

A

Divided into two categories:

1) Neurogenic (autoimmune)
2) Neuroglycopaenia

49
Q

Neurogenic symptoms of hypoglycaemia

A
  • symptoms triggered by falling glucose levels

- activated by ANS & mediated by sympathoadrenal release of catecholamines and Ach

50
Q

Neuroglycopaenic symptoms of hypoglycaemia

A

-symptoms occur as a result of neuronal glucose deprivation

Include:

  • confusion
  • difficulty speaking
  • ataxia
  • parathesia
  • seizures
  • coma
  • death

Molecular basis of disease (31 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions